Name: Acute Care
Brand: ECRI
SKU: NIL
Availability: InStock
Rating: 4.6 (5 reviews)

ISMP Newsroom

ISMP

Media Inquiries

For media inquiries and interviews with ISMP's subject matter experts, please contact Renee Brehio at rbrehio@ismp.org.

Tous les articles

Press Coverage

Press Coverage

Challenges with Transdermal Medication Patches Can Lead to Errors

This article appeared on the Home Healthcare Now website on July 31, 2023.

Press Coverage

Press Coverage

IV Workflow Management Systems: A Century in the Making

This article appeared on the Pharmacy Practice News website on June 22, 2023.

Press Coverage

Press Coverage

Perioperative Settings Benefit from Better Attention to Med Safety

This article appeared on the Pharmacy Practice News website on June 12, 2023.

Press Coverage

Press Coverage

Medication Errors: The Year in Review

This article appeared on the Pharmacy Practice News website on April 12, 2023.

Press Coverage

Press Coverage

Medication Safety Week Reflections: I Am Medication Safety

This article appeared on the Pharmacy Times website on April 1, 2023.

Press Coverage

Press Coverage

I.V. Push Medications: An Evidence-Based Practice Guide

This article appeared on the American Nurse website on April 1, 2023.

Stay Connected

Get medication safety news, event invitations and updates straight to your inbox!

Social Media

View the Latest from ECRI

News

HANYS Marketplace partners with ECRI to improve patient safety and reduce preventable harm in healthcare

HANYS Marketplace® has partnered with ECRI, a nonprofit organization advancing the safety and quality of healthcare, to provide New York’s hospitals and health systems with evidence-based solutions...

News

ECRI Names Cottage Health Winner of 2026 Health Technology Excellence Award

Innovative blood management initiative recognized for reducing waste through proactive interfacility transfers. ECRI, a nonprofit organization advancing the safety and quality of healthcare, has ho...

News

ECRI & ISMP Statement in Response to PCAC Decision on Compounding Peptides

The FDA Pharmacy Compounding Advisory Committee (PCAC) decided to recommend adding most of the peptides under consideration during its July 23-24, 2026, meeting to the 503A Bulks List, despite subs...

View all